291 related articles for article (PubMed ID: 29332347)
61. Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-λ1 or PEG-interferon-λ1.
Tian S; Hui X; Fan Z; Li Q; Zhang J; Yang X; Ma X; Huang B; Chen D; Chen H
FASEB J; 2014 Aug; 28(8):3528-39. PubMed ID: 24769671
[TBL] [Abstract][Full Text] [Related]
62. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
63. Downregulation of p21(waf/cip-1) mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-gamma.
Detjen KM; Murphy D; Welzel M; Farwig K; Wiedenmann B; Rosewicz S
Exp Cell Res; 2003 Jan; 282(2):78-89. PubMed ID: 12531694
[TBL] [Abstract][Full Text] [Related]
64. IL-8/CXCR2 mediates tropism of human bone marrow-derived mesenchymal stem cells toward CD133
Ma X; Chen J; Liu J; Xu B; Liang X; Yang X; Feng Y; Liang X; Liu J
J Cell Physiol; 2021 Apr; 236(4):3114-3128. PubMed ID: 33078417
[TBL] [Abstract][Full Text] [Related]
65. Bone Marrow-Derived Mesenchymal Stem Cell-Mediated Dual-Gene Therapy for Glioblastoma.
Shi S; Zhang M; Guo R; Miao Y; Li B
Hum Gene Ther; 2019 Jan; 30(1):106-117. PubMed ID: 29993289
[TBL] [Abstract][Full Text] [Related]
66. Combining mesenchymal stem cell sheets with platelet-rich plasma gel/calcium phosphate particles: a novel strategy to promote bone regeneration.
Qi Y; Niu L; Zhao T; Shi Z; Di T; Feng G; Li J; Huang Z
Stem Cell Res Ther; 2015 Dec; 6():256. PubMed ID: 26689714
[TBL] [Abstract][Full Text] [Related]
67. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
[TBL] [Abstract][Full Text] [Related]
68. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
Sun WJ; Huang H; He B; Hu DH; Li PH; Yu YJ; Zhou XH; Lv Z; Zhou L; Hu TY; Yao ZC; Lu MD; Shen X; Zheng ZQ
Biochem Pharmacol; 2017 Mar; 127():90-100. PubMed ID: 28012958
[TBL] [Abstract][Full Text] [Related]
69. Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach.
Takeba Y; Ohta Y; Ootaki M; Kobayashi T; Kida K; Watanabe M; Koizumi S; Otsubo T; Iiri T; Matsumoto N
Tumour Biol; 2021; 43(1):309-325. PubMed ID: 34897107
[TBL] [Abstract][Full Text] [Related]
70. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
[TBL] [Abstract][Full Text] [Related]
71. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
Liu R; Tang C; Shen A; Luo H; Wei X; Zheng D; Sun C; Li Z; Zhu D; Li T; Wu Z
Oncotarget; 2016 Dec; 7(51):85079-85096. PubMed ID: 27835881
[TBL] [Abstract][Full Text] [Related]
72. [Construction of recombinant plasmid pIRES-GM-CSF-IL-21 and its therapeutic effect on orthotopically transplanted liver cancer in mice].
Cheng MR; Li Q; Hong XW; Ye T; He B; Cheng ZJ; Xu HZ; Zha BB
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):661-5. PubMed ID: 22340045
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
74. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
[TBL] [Abstract][Full Text] [Related]
75. NT3
Wu K; Huang D; Zhu C; Kasanga EA; Zhang Y; Yu E; Zhang H; Ni Z; Ye S; Zhang C; Hu J; Zhuge Q; Yang J
Stem Cell Res Ther; 2019 Oct; 10(1):311. PubMed ID: 31651375
[TBL] [Abstract][Full Text] [Related]
76. Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system.
Zhang L; Su XS; Ye JS; Wang YY; Guan Z; Yin YF
Stem Cell Res Ther; 2015 Mar; 6(1):45. PubMed ID: 25889932
[TBL] [Abstract][Full Text] [Related]
77. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.
Yuan X; Zhang Q; Li Z; Zhang X; Bao S; Fan D; Ru Y; Dong S; Zhang Y; Zhang Y; Ye Z; Xiong D
Cancer Lett; 2016 Oct; 381(1):85-95. PubMed ID: 27450327
[TBL] [Abstract][Full Text] [Related]
78. NGF protects bone marrow mesenchymal stem cells against 2,5-hexanedione-induced apoptosis in vitro via Akt/Bad signal pathway.
Wang Q; Chen R; Zhang C; Inam-U-Llah ; Piao F; Shi X
Mol Cell Biochem; 2019 Jul; 457(1-2):133-143. PubMed ID: 30911955
[TBL] [Abstract][Full Text] [Related]
79. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
[TBL] [Abstract][Full Text] [Related]
80. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
